Lung Cancer: 2017 New Directions
Presented by Jonathan Goldman, MD
About the Lecture
Jonathan Goldman, MD, UCLA Assistant Professor, Director of Clinical Trials in Thoracic Oncology and Associate Director of Drug Development at UCLA, discusses recent developments in lung cancer care, including exciting recent advances in targeted therapy and immune therapy. He reviews the current chemotherapies and explains how the newer drugs may be incorporated into treatment plans. He also discusses how clinical trials are developed, and explains how and why they may be helpful in a patient’s care.
About the Speaker
Jonathan Goldman, MD, is the Director of Clinical Trials in Thoracic Oncology and the Associate Director of Drug Development. His research is focused on cancer drug development and on treatment for lung cancers. He develops novel anti-cancer drugs that have been identified in the lab and investigates their toxicity and efficacy for patients in the clinic.